Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-12-03T20:02:28.069Z Has data issue: false hasContentIssue false

P.003 Health-related quality of life (HRQOL) for genetically determined leukoencephalopathy patients and their families

Published online by Cambridge University Press:  17 June 2016

A Mirchi
Affiliation:
(Montréal)
F Pelletier
Affiliation:
(Montréal)
LT Tran
Affiliation:
(Montréal)
A Pizzino
Affiliation:
(Washington)
M Dilenge
Affiliation:
(Montréal)
N Braverman
Affiliation:
(Montréal)
A Vanderver
Affiliation:
(Washington)
F Roncarolo
Affiliation:
(Montréal)
G Bernard
Affiliation:
(Montréal)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Genetic leukoencephalopathies are a group of neurodegenerative diseases imposing a great burden on patients and families. There is no previous systematic study looking at the impacts of these diseases. Methods: HRQOL was assessed using the Pediatric Quality of Life Inventory (PedsQL) model. A total of 24 patients with genetically determined leukoencephalopathies and their family members completed the PedsQL questionnaires. Detailed clinical assessments were performed at the time the questionnaires were filled. HRQOL results were correlated with the severity of the clinical features and the presence vs. absence of a definitive molecular diagnosis. Results: Preliminary results show lower PedsQL total scores for patients without compared to with a molecular diagnosis. Emotional and physical functioning scores were significantly impaired in patients without a molecular diagnosis. Lower total scores were obtained for patients who presented more severe clinical features such as lost ambulatory functions and dysphagia. Conclusions: Overall, our preliminary results indicate that patients without a molecular diagnosis have an impaired HRQOL and that more severely affected patients have a poorer HRQOL. Further analyses and studies on a larger population of patients in a prospective fashion are required to assess the burden of these diseases and identify potential modifiable factors.

Type
Poster Presentations
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2016